Back to GOLDMAN SACHS GROUP INC GOLDMAN SACHS GROUP INC

ORTXORTX
5 quarters

Position history for GOLDMAN SACHS GROUP INCGOLDMAN SACHS GROUP INC's holdings in ORCHARD THERAPEUTICS PLC

GOLDMAN SACHS GROUP INC previously held 0 shares of ORTX (ORCHARD THERAPEUTICS PLC), worth $0 as of 2024-Q1.

Final Value

$0

Final Shares

0

Total Value Change

-$152,035

Total Shares Change

-28,312

Quarter-by-Quarter History
QuarterActionSharesChangeValueWeightPriceConviction
2024-Q1
Latest
Exited
0
-100.0%
$00.0%—
0
2023-Q4
New
137,520
-
$2.3M0.0%—
36
2023-Q3
Exited
0
-100.0%
$00.0%—
0
2023-Q2
Increased
28,364
+0.2%
$147,7760.0%—
15
2023-Q1
New
28,312
-
$152,0350.0%—
34

Other major holders of ORTX: FEDERATED HERMES, INC., LMR Partners LLP, TUDOR INVESTMENT CORP ET AL

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used